Kukje Pharma Co., Ltd.
KRX:002720.KS
5450 (KRW) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 135,372.691 | 126,583.403 | 119,745.569 | 130,394.721 | 111,121.601 | 107,681.163 | 123,310.224 | 120,684.006 | 117,636.992 | 122,426.377 | 120,461.297 | 126,768.061 | 104,857.016 | 131,308.308 | 122,564.775 | 121,637.704 | 103,756.103 | 97,272.857 |
Cost of Revenue
| 68,907.707 | 63,329.27 | 65,275.254 | 65,590.075 | 58,136.153 | 58,871.967 | 71,838.725 | 66,903.453 | 64,860.724 | 75,259.686 | 72,687.893 | 82,361.182 | 60,064.242 | 66,575.5 | 62,438.044 | 54,051.744 | 46,034.094 | 39,839.65 |
Gross Profit
| 66,464.983 | 63,254.133 | 54,470.315 | 64,804.646 | 52,985.448 | 48,809.196 | 51,471.5 | 53,780.552 | 52,776.268 | 47,166.691 | 47,773.404 | 44,406.878 | 44,792.774 | 64,732.808 | 60,126.731 | 67,585.96 | 57,722.009 | 57,433.207 |
Gross Profit Ratio
| 0.491 | 0.5 | 0.455 | 0.497 | 0.477 | 0.453 | 0.417 | 0.446 | 0.449 | 0.385 | 0.397 | 0.35 | 0.427 | 0.493 | 0.491 | 0.556 | 0.556 | 0.59 |
Reseach & Development Expenses
| 4,299.35 | 1,966.817 | 2,772.337 | 3,036.649 | 2,604.009 | 3,591.544 | 3,291.103 | 1,330.696 | 1,066.167 | 1,533.933 | 816.58 | 1,027.499 | 0 | 474.433 | 947.58 | 673.677 | 562.942 | 660.922 |
General & Administrative Expenses
| 6,907.15 | 4,827.961 | 4,274.185 | 4,457.856 | 5,458.125 | 7,858.076 | 8,496.083 | 8,760.551 | 8,224.174 | 6,993.068 | 6,476.406 | 6,583.612 | 5,364.995 | 5,675.885 | 5,151.719 | 5,230.678 | 4,871.493 | 4,510.744 |
Selling & Marketing Expenses
| 36,229.062 | 22,748.393 | 22,053.403 | 16,704.13 | 11,829.855 | 8,624.247 | 9,796.016 | 12,477.998 | 16,081.089 | 16,797.548 | 18,168.14 | 31,749.147 | 18,676.816 | 25,415.23 | 21,371.953 | 22,575.136 | 16,956.902 | 17,581.682 |
SG&A
| 64,154.776 | 27,576.354 | 26,327.588 | 21,161.986 | 17,287.98 | 16,482.323 | 18,292.099 | 21,238.549 | 24,305.263 | 23,790.616 | 24,644.546 | 38,332.759 | 24,041.811 | 31,091.115 | 26,523.672 | 27,805.814 | 21,828.395 | 22,092.426 |
Other Expenses
| -2,249.269 | 28,438.434 | 27,046.293 | 34,564.637 | 27,522.702 | 562.36 | 575.348 | 103.777 | -2,271.27 | -2,803.693 | 830.793 | 242.814 | 273.185 | 1,400.818 | 993.176 | 691.31 | 587.007 | -141.473 |
Operating Expenses
| 68,454.126 | 57,981.605 | 56,146.218 | 58,763.272 | 47,414.691 | 45,522.179 | 48,907.323 | 49,811.287 | 50,678.376 | 48,589.645 | 46,726.446 | 59,114.772 | 41,773.293 | 56,718.952 | 51,379.933 | 53,713.381 | 45,038.902 | 44,121.001 |
Operating Income
| -1,989.143 | 5,272.527 | -401.293 | 6,041.374 | 925.939 | 3,287.018 | 2,564.176 | 3,969.266 | 2,097.892 | -1,422.954 | 1,046.958 | -14,707.894 | 3,288.523 | 8,013.857 | 8,746.799 | 13,872.58 | 12,683.107 | 13,312.209 |
Operating Income Ratio
| -0.015 | 0.042 | -0.003 | 0.046 | 0.008 | 0.031 | 0.021 | 0.033 | 0.018 | -0.012 | 0.009 | -0.116 | 0.031 | 0.061 | 0.071 | 0.114 | 0.122 | 0.137 |
Total Other Income Expenses Net
| -4,691.468 | -527.441 | -708.964 | -447.795 | -804.498 | -2,054.101 | -511.484 | -1,273.048 | -1,405.708 | -4,253.175 | -1,423.807 | -1,127.972 | -1,410.504 | -208.875 | 189.869 | -2,976.254 | -997.118 | -843.516 |
Income Before Tax
| -6,680.611 | 4,745.086 | -1,110.257 | 5,593.579 | 121.441 | 2,830.235 | 2,052.692 | 1,770.44 | -1,681.886 | -5,676.129 | 522.341 | -15,835.866 | 1,878.019 | 7,804.982 | 8,936.668 | 10,896.326 | 11,685.989 | 12,468.693 |
Income Before Tax Ratio
| -0.049 | 0.037 | -0.009 | 0.043 | 0.001 | 0.026 | 0.017 | 0.015 | -0.014 | -0.046 | 0.004 | -0.125 | 0.018 | 0.059 | 0.073 | 0.09 | 0.113 | 0.128 |
Income Tax Expense
| 1,734.277 | 1,202.313 | 445.535 | 3,399.01 | 4,883.253 | 647.361 | 1,014.037 | 971.501 | 4,202.573 | 1,241.123 | -1,149.599 | 3,104.16 | 908.493 | 3,491.43 | 2,077.667 | 4,292.187 | 5,461.344 | 6,325.175 |
Net Income
| -8,415.187 | 3,557.333 | -1,555.791 | 2,203.001 | -4,761.812 | 2,192.621 | 1,092.249 | 773.062 | -5,942.879 | -6,932.106 | 2,125.167 | -18,940.084 | 927.806 | 4,313.552 | 6,859.001 | 6,604.14 | 6,224.645 | 6,143.517 |
Net Income Ratio
| -0.062 | 0.028 | -0.013 | 0.017 | -0.043 | 0.02 | 0.009 | 0.006 | -0.051 | -0.057 | 0.018 | -0.149 | 0.009 | 0.033 | 0.056 | 0.054 | 0.06 | 0.063 |
EPS
| -415.49 | 175.58 | -76.77 | 103.5 | -234.89 | 108.07 | 54.2 | 37.46 | -292.38 | -346.67 | 106.36 | -947.3 | 46.61 | 229.75 | 368.66 | 372.64 | 342.9 | 323.03 |
EPS Diluted
| -415.49 | 175.58 | -76.77 | 103.5 | -234.89 | 107.98 | 54.2 | 37.46 | -292.38 | -346.67 | 106.36 | -947.3 | 46.61 | 229.75 | 368.66 | 372.64 | 342.9 | 323.03 |
EBITDA
| 2,214.99 | 10,760.449 | 4,017.697 | 9,496.609 | 4,176.772 | 7,625.037 | 5,466.378 | 5,930.11 | 3,081.08 | -421.603 | 6,023.303 | -10,019.628 | 6,387.19 | 13,655.472 | 16,370.995 | 17,187.757 | 15,698.11 | 15,843.246 |
EBITDA Ratio
| 0.016 | 0.085 | 0.034 | 0.073 | 0.038 | 0.071 | 0.044 | 0.049 | 0.026 | -0.003 | 0.05 | -0.079 | 0.061 | 0.104 | 0.134 | 0.141 | 0.151 | 0.163 |